A study by González-Ferrero et al.42 measured galectin-3, fatty acid-binding protein-4 (FABP4), and soluble receptor for advanced glycation end products (sRAGE) and found no differences in biomarker levels between individuals with AF alone and those with concomitant heart failure. This evidence concerns the gene AGER and heart failure.